Portfolio

Entozyme

Unlocking the latent potential of the black soldier fly (BSF) with a novel genetic design platform.
Up Arrow Icon

Entozyme

→

Leaders
Maciej Maselko
Maciej Maselko
Co-Founder and CEO
Investment Team
challenges
The BSF industry operates at industrial scale but remains limited to low-margin commodity goods like protein meal and fertiliser.
solution
Entozyme's genetic toolkit unlocks the potential of BSF for enhanced waste processing and repurposes it to biomanufacture high-value therapeutics, nutraceutical oils and specialty biomaterials. Its first go-to-market is Omega-3 oil, where demand far exceeds supply from traditional aquaculture.
For founders

Building for the systems that matter? Pitch us.

We back founders turning breakthrough science into category-defining companies.

Submit your pitch
For investors

Invest with Main Sequence

Access Australia's deep tech frontier alongside us.

Investor enquiries